Equasens Société anonyme (EPA:EQS)

Market Cap	417.84M -24.6%
Revenue (ttm)	245.05M +9.0%
Net Income	41.04M +13.1%
EPS	2.73 +13.2%
Shares Out	15.03M
PE Ratio	10.20
Forward PE	8.76
Dividend	1.40 (5.04%)
Ex-Dividend Date	Jul 1, 2026

Volume	21,675
Open	27.30
Previous Close	27.60
Day's Range	27.05 - 28.00
52-Week Range	25.55 - 45.35
Beta	0.57
Analysts	Strong Buy
Price Target	52.30 (+88.13%)
Est. Earnings	Nov 9, 2026

About Equasens Société anonyme

Equasens Société anonyme provides healthcare IT solutions in France, Italy, Belgium, Germany, the United Kingdom, and internationally. The company operates through Sales of Configurations and Hardware, Maintenance Services and Subscriptions, and Software and Services segments. The company engages in publishing and distribution of pharmacy, practice, management software and related offerings for pharmacies, medical-social establishments, doctors, and medical auxiliaries; distribution of computer equipment, turnkey installation and training; afte...

• Industry: Health Information Services
• Sector: Healthcare
• Founded: 1996
• Employees: 1,500
• Stock Exchange: Euronext Paris
• Ticker Symbol: EQS

Financial Performance

In 2025, Equasens Société anonyme's revenue was 236.52 million, an increase of 9.12% compared to the previous year's 216.75 million. Earnings were 39.33 million, an increase of 8.55%.

Analyst Summary

According to 4 analysts, the average rating for EQS stock is "Strong Buy." The 12-month stock price target is €52.30, which is an increase of 88.13% from the latest price.

Price Target

€52.30

(88.13% upside)

Analyst Consensus: Strong Buy

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Nov 6, 2026

Data Sources Report a data error